Call to PBS list weight loss jabs

Manufacturers of GLP-1 RAs such as semaglutide are being urged to invest in listing the medications on the PBS to treat obesity  The Royal Australian College of General Practitioners is calling for “effective obesity-management" medications including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to be subsidised on the Pharmaceutical Benefits Scheme (PBS), “to reduce health inequity”.